Annual Total Long Term Liabilities
$7.96 M
-$11.15 M-58.36%
31 March 2024
Summary:
Taro Pharmaceutical Industries annual total long term liabilities is currently $7.96 million, with the most recent change of -$11.15 million (-58.36%) on 31 March 2024. During the last 3 years, it has fallen by -$27.16 million (-77.34%).TARO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$7.96 M
-$2.07 M-20.65%
31 March 2024
Summary:
Taro Pharmaceutical Industries quarterly total long term liabilities is currently $7.96 million, with the most recent change of -$2.07 million (-20.65%) on 31 March 2024. Over the past year, it has dropped by -$2.47 million (-23.71%).TARO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.4% | -23.7% |
| 3 y3 years | -77.3% | -73.6% |
| 5 y5 years | +7.8% | -10.6% |
TARO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -96.0% | -96.0% |
Taro Pharmaceutical Industries Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $7.96 M(-58.4%) | $7.96 M(-20.7%) |
| Dec 2023 | - | $10.03 M(-3.9%) |
| Sept 2023 | - | $10.43 M(-9.4%) |
| June 2023 | - | $11.51 M(-39.8%) |
| Mar 2023 | $19.11 M(-41.7%) | $19.11 M(-26.9%) |
| Sept 2022 | - | $26.15 M(-17.8%) |
| June 2022 | - | $31.83 M(-3.0%) |
| Mar 2022 | $32.80 M(-6.6%) | $32.80 M(+3.6%) |
| Dec 2021 | - | $31.67 M(+5.3%) |
| Sept 2021 | - | $30.09 M(+15.3%) |
| June 2021 | - | $26.10 M(-25.7%) |
| Mar 2021 | $35.12 M(+300.8%) | $35.12 M(-5.5%) |
| Dec 2020 | - | $37.17 M(-7.2%) |
| Sept 2020 | - | $40.05 M(-63.3%) |
| June 2020 | - | $109.07 M(+1144.8%) |
| Mar 2020 | $8.76 M(+18.7%) | $8.76 M(+7.1%) |
| Dec 2019 | - | $8.18 M(-8.1%) |
| Sept 2019 | - | $8.90 M(+9.6%) |
| June 2019 | - | $8.12 M(+10.0%) |
| Mar 2019 | $7.38 M(+4.6%) | $7.38 M(+37.7%) |
| Dec 2018 | - | $5.36 M(+15.1%) |
| Sept 2018 | - | $4.66 M(-10.4%) |
| June 2018 | - | $5.20 M(-26.4%) |
| Mar 2018 | $7.05 M(+15.5%) | $7.05 M(+45.7%) |
| Dec 2017 | - | $4.84 M(+1.5%) |
| Sept 2017 | - | $4.77 M(-20.4%) |
| June 2017 | - | $6.00 M(-1.9%) |
| Mar 2017 | $6.11 M(+12.6%) | $6.11 M(+12.0%) |
| Dec 2016 | - | $5.46 M(+5.3%) |
| Sept 2016 | - | $5.18 M(-6.1%) |
| June 2016 | - | $5.52 M(+1.7%) |
| Mar 2016 | $5.43 M(-47.6%) | $5.43 M(+18.1%) |
| Dec 2015 | - | $4.59 M(-52.4%) |
| Sept 2015 | - | $9.65 M(-3.5%) |
| June 2015 | - | $10.00 M(-3.4%) |
| Mar 2015 | $10.36 M(-1.2%) | $10.36 M(+2.9%) |
| Dec 2014 | - | $10.07 M(-2.3%) |
| Sept 2014 | - | $10.30 M(-0.3%) |
| June 2014 | - | $10.33 M(-1.4%) |
| Mar 2014 | $10.48 M(-54.7%) | $10.48 M(-6.7%) |
| Dec 2013 | - | $11.23 M(-50.1%) |
| Sept 2013 | - | $22.51 M(-1.4%) |
| June 2013 | - | $22.84 M(-1.3%) |
| Mar 2013 | $23.14 M(-33.0%) | $23.14 M(-0.9%) |
| Dec 2012 | - | $23.36 M(-29.2%) |
| Sept 2012 | - | $33.01 M(-0.5%) |
| June 2012 | - | $33.19 M(-4.0%) |
| Mar 2012 | $34.57 M(+0.5%) | $34.57 M(+0.5%) |
| Dec 2011 | $34.40 M(-18.4%) | $34.40 M(-9.4%) |
| Sept 2011 | - | $37.95 M(-15.5%) |
| June 2011 | - | $44.91 M(+5.5%) |
| Mar 2011 | - | $42.58 M(+1.0%) |
| Dec 2010 | $42.14 M(-15.3%) | $42.14 M(-19.9%) |
| Sept 2010 | - | $52.59 M(+6.9%) |
| June 2010 | - | $49.19 M(-1.2%) |
| Dec 2009 | $49.78 M | $49.78 M(-29.4%) |
| Sept 2009 | - | $70.53 M(-4.4%) |
| June 2009 | - | $73.81 M(-11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $83.35 M(+20.0%) |
| Dec 2008 | $69.48 M(-28.6%) | $69.48 M(-26.7%) |
| Sept 2008 | - | $94.84 M(-44.1%) |
| Dec 2007 | $97.25 M(-12.6%) | - |
| Dec 2006 | $111.33 M(-34.4%) | - |
| Dec 2005 | $169.75 M(-13.6%) | $169.75 M(-14.3%) |
| Sept 2005 | - | $198.13 M(+5.7%) |
| June 2005 | - | $187.50 M(-2.5%) |
| Mar 2005 | - | $192.37 M(-2.1%) |
| Dec 2004 | $196.50 M(+20.1%) | $196.50 M(+0.8%) |
| Sept 2004 | - | $195.04 M(+3.4%) |
| June 2004 | - | $188.65 M(+4.9%) |
| Mar 2004 | - | $179.78 M(+9.8%) |
| Dec 2003 | $163.67 M(+219.0%) | $163.67 M(+47.2%) |
| Sept 2003 | - | $111.23 M(-4.0%) |
| June 2003 | - | $115.81 M(+87.8%) |
| Mar 2003 | - | $61.66 M(+20.2%) |
| Dec 2002 | $51.30 M(-4.7%) | $51.30 M(-5.2%) |
| Sept 2002 | - | $54.14 M(+1.6%) |
| June 2002 | - | $53.26 M(-3.4%) |
| Mar 2002 | - | $55.12 M(+2.4%) |
| Dec 2001 | $53.84 M(+28.5%) | $53.84 M(-1.8%) |
| Sept 2001 | - | $54.82 M(+6.9%) |
| June 2001 | - | $51.30 M(+17.5%) |
| Mar 2001 | - | $43.67 M(+4.2%) |
| Dec 2000 | $41.91 M(+64.4%) | $41.91 M(+21.9%) |
| Sept 2000 | - | $34.38 M(+25.7%) |
| June 2000 | - | $27.35 M(+10.5%) |
| Mar 2000 | - | $24.75 M(-2.9%) |
| Dec 1999 | $25.50 M(+42.7%) | $25.50 M(-12.1%) |
| Sept 1999 | - | $29.00 M(+43.6%) |
| June 1999 | - | $20.20 M(+12.8%) |
| Mar 1999 | - | $17.90 M(+0.2%) |
| Dec 1998 | $17.87 M(+4.5%) | $17.87 M(+3.9%) |
| Mar 1998 | - | $17.20 M(+0.6%) |
| Dec 1997 | $17.10 M(+11.8%) | $17.10 M(+6.2%) |
| Sept 1997 | - | $16.10 M(-1.2%) |
| June 1997 | - | $16.30 M(+3.2%) |
| Mar 1997 | - | $15.80 M(+3.3%) |
| Dec 1996 | $15.30 M(+28.6%) | $15.30 M(+5.5%) |
| Sept 1996 | - | $14.50 M(0.0%) |
| June 1996 | - | $14.50 M(+11.5%) |
| Mar 1996 | - | $13.00 M(+9.2%) |
| Dec 1995 | $11.90 M(+495.0%) | $11.90 M(+495.0%) |
| Dec 1994 | $2.00 M(-25.9%) | $2.00 M(-25.9%) |
| Dec 1993 | $2.70 M(-32.5%) | $2.70 M(-32.5%) |
| Dec 1992 | $4.00 M(+53.8%) | $4.00 M(+135.3%) |
| Sept 1992 | - | $1.70 M(-15.0%) |
| June 1992 | - | $2.00 M(+53.8%) |
| Mar 1992 | - | $1.30 M(-50.0%) |
| Dec 1991 | $2.60 M(-27.8%) | $2.60 M(+116.7%) |
| Sept 1991 | - | $1.20 M(-14.3%) |
| June 1991 | - | $1.40 M(-48.1%) |
| Mar 1991 | - | $2.70 M(-25.0%) |
| Dec 1990 | $3.60 M(+5.9%) | $3.60 M(+33.3%) |
| Mar 1990 | - | $2.70 M(-20.6%) |
| Dec 1989 | $3.40 M(-2.9%) | $3.40 M(-2.9%) |
| Dec 1988 | $3.50 M(+12.9%) | $3.50 M(+12.9%) |
| Dec 1987 | $3.10 M | $3.10 M |
FAQ
- What is Taro Pharmaceutical Industries annual total long term liabilities?
- What is the all time high annual total long term liabilities for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual total long term liabilities year-on-year change?
- What is Taro Pharmaceutical Industries quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly long term liabilities year-on-year change?
What is Taro Pharmaceutical Industries annual total long term liabilities?
The current annual total long term liabilities of TARO is $7.96 M
What is the all time high annual total long term liabilities for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual total long term liabilities is $196.50 M
What is Taro Pharmaceutical Industries annual total long term liabilities year-on-year change?
Over the past year, TARO annual total long term liabilities has changed by -$11.15 M (-58.36%)
What is Taro Pharmaceutical Industries quarterly total long term liabilities?
The current quarterly long term liabilities of TARO is $7.96 M
What is the all time high quarterly long term liabilities for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly total long term liabilities is $198.13 M
What is Taro Pharmaceutical Industries quarterly long term liabilities year-on-year change?
Over the past year, TARO quarterly total long term liabilities has changed by -$2.47 M (-23.71%)